Actinium Pharmaceuticals ATNM
-
-
-
已收盤：-
淨值比明細
年季 | 收盤價 | 權益總計(百萬) | 稅後權益報酬率(%) | 稅後純益(百萬) | 稅後資產報酬率(%) | 資產總計(百萬) |
|---|---|---|---|---|---|---|
| 2025Q3 | 1.60 | 14 | -31.29 | -5 | -8.61 | 56 |
| 2025Q2 | 1.40 | 19 | -30.77 | -7 | -10.45 | 63 |
| 2025Q1 | 1.61 | 26 | -54.53 | -16 | -21.90 | 69 |
| 2024Q4 | 1.26 | 33 | -18.75 | -7 | -8.37 | 77 |
| 2024Q3 | 1.88 | 38 | -28.20 | -12 | -13.45 | 82 |
| 2024Q2 | 7.40 | 44 | -25.89 | -11 | -12.74 | 90 |
| 2024Q1 | 7.83 | 44 | -21.61 | -9 | -10.21 | 88 |
| 2023Q4 | 5.08 | 36 | -23.32 | -9 | -10.94 | 81 |
| 2023Q3 | 5.92 | 44 | -27.47 | -13 | -14.12 | 89 |
| 2023Q2 | 7.42 | 53 | -27.53 | -15 | -15.10 | 99 |
| 2023Q1 | 9.45 | 57 | -17.85 | -11 | -10.21 | 102 |
| 2022Q4 | 10.65 | 66 | -15.46 | -11 | -9.22 | 114 |
| 2022Q3 | 7.38 | 71 | -12.68 | -9 | -7.94 | 117 |
| 2022Q2 | 4.81 | 78 | -10.57 | -8 | -7.91 | 122 |
| 2022Q1 | 5.11 | 69 | -7.20 | -5 | -6.62 | 75 |
| 2021Q4 | 6.01 | 74 | -10.41 | -8 | -9.72 | 80 |
| 2021Q3 | 8.86 | 80 | -7.99 | -6 | -7.60 | 84 |
| 2021Q2 | 7.91 | 80 | -6.64 | -5 | -6.29 | 84 |
| 2021Q1 | 7.62 | 71 | -8.06 | -5 | -7.52 | 75 |
| 2020Q4 | 7.80 | 61 | -11.95 | -6 | -10.91 | 66 |